Overview
Hiral Shah is an Oncologist in Columbus, Ohio. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). Her top areas of expertise are Melanoma of the Eye, Metastatic Uveal Melanoma, Small Lymphocytic Lymphoma (SLL), and Myelodysplastic Syndrome (MDS). Dr. Shah is currently accepting new patients.
Her clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
3100 Plaza Properties Blvd, Columbus, OH 43219
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Osu Internal Medicine LLC
Marcos De Lima is a Hematologist Oncology specialist and an Oncologist in Columbus, Ohio. Dr. De Lima is rated as an Elite provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Graft. Dr. De Lima is currently accepting new patients.
Steven Devine is a Hematologist and an Oncologist in Columbus, Ohio. Dr. Devine is rated as an Elite provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant.
Ohiohealth Corporation
Michael Becker is an Oncologist and a Hematologist in Columbus, Ohio. Dr. Becker is rated as a Distinguished provider by MediFind in the treatment of Myelodysplastic Syndrome (MDS). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Transplant, and Thrombectomy. Dr. Becker is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Melanoma of the EyeDr. Shah isDistinguished. Learn about Melanoma of the Eye.
- Metastatic Uveal MelanomaDr. Shah isDistinguished. Learn about Metastatic Uveal Melanoma.
- Small Lymphocytic Lymphoma (SLL)Dr. Shah isDistinguished. Learn about Small Lymphocytic Lymphoma (SLL).
- Advanced
- Breast CancerDr. Shah isAdvanced. Learn about Breast Cancer.
- MalabsorptionDr. Shah isAdvanced. Learn about Malabsorption.
- Merkel Cell CarcinomaDr. Shah isAdvanced. Learn about Merkel Cell Carcinoma.
- Myelodysplastic Syndrome (MDS)
- Paget Disease of the BreastDr. Shah isAdvanced. Learn about Paget Disease of the Breast.
- Experienced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Shah isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult Soft Tissue SarcomaDr. Shah isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Shah isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer